The retina is a thin, light-sensitive layer at the back of the eye responsible for converting light into electrical signals that are processed by the brain to form vision. It contains two main types of photoreceptor cells: rods, which are responsible for vision in low light, and cones, which enable color and daylight vision. In dogs affected by PRA cord1, these photoreceptor cells progressively deteriorate due to a genetic defect, leading to irreversible vision impairment.
Clinical signs of PRA cord1 often begin early in life, though the age of onset can vary depending on breed and genetic background. One of the earliest signs is night blindness, where affected dogs struggle to see in dim lighting or darkness. Owners may notice hesitation when navigating poorly lit areas, reluctance to go outside at night, or increased bumping into objects in low light conditions. As the disease progresses, daytime vision also becomes affected. Dogs may have difficulty locating objects, recognizing familiar surroundings, or judging distances. Eventually, the condition can lead to complete blindness. Despite this, PRA cord1 is generally not painful, and many dogs adapt well to vision loss using their other senses.
The PRA cord1 DNA Health Test is designed to detect the specific genetic mutation associated with this form of Progressive Retinal Atrophy. Testing is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine the dog’s genetic status. Since DNA does not change over a dog’s lifetime, testing can be performed at any age, including in puppies before clinical signs develop.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the PRA cord1 mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but is typically unaffected in early life. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Progressive Retinal Atrophy (cord1) and associated vision loss.
Genetic testing for PRA cord1 is highly valuable for breeders, veterinarians, and dog owners. Breeders can use test results to make informed mating decisions that reduce the prevalence of the disease while preserving healthy genetic diversity within the breed. Avoiding carrier-to-carrier breeding significantly reduces the risk of producing affected puppies.
For dog owners, understanding a dog’s genetic status allows for early monitoring of eye health through routine ophthalmic examinations. Dogs identified as at risk can benefit from proactive management strategies such as environmental adjustments, consistent home layouts, and safety precautions to support mobility and confidence as vision declines. While there is currently no cure for PRA cord1, early diagnosis helps owners prepare for progressive vision loss and improve quality of life.
The Progressive Retinal Atrophy (PRA cord1) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine ocular health, and helps reduce the impact of this inherited retinal disorder in future generations.
